第1章 目錄

第2章 簡介

第3章 產業概要

第4章 未滿足需求

第5章 市場機會分析

歐洲各國的真空輔助切片檢查(VAB)設備市場

解決方案套組

中國的VAB設備採用的增加

歐洲的前列腺癌檢驗市場

第6章 推動市場要素和機會

推動市場要素

市場障礙

第7章 競爭評估

概要

系統為基礎分類

第8章 開發平台評估

概要

第9章 臨床試驗分析

第10章 現在/未來的主要企業

企業策略趨勢

企業簡介

第11章 市場預測

企業的市場佔有率

各市場區隔

各地區

第12章 附錄

目錄

Product Code: GDME1086CFR

Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions.

Countries in the Asia Pacific (APAC) region such as Japan and China and the South American country of Brazil will have growth rates that are more than double the global CAGR. This is primarily due to the increased market access of each country's population to healthcare resources and the increased adoption of more expensive core needle biopsy devices over fine needle aspiration devices.

Scope

An overview of biopsy devices, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.

Annualized APAC biopsy devices market revenue and future forecasts from 2010 to 2012, forecast for 7 years to 2019.

Investigation of current and future market competition for biopsy devices.

Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.